Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm

Clinical Infectious Diseases

Volumn 57, Issue 3, 2013, Pages 476-477

  Skowronski, Danuta M ^a   Janjua, Naveed Z ^a   De Serres, Gaston ^b  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AMINO ACID SUBSTITUTION; CLINICAL EFFECTIVENESS; GENE SEQUENCE; HEMAGGLUTINATION INHIBITION TEST; HOST; HUMAN; IMMUNITY; INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; LETTER; PRIORITY JOURNAL; VIRUS MUTATION;

FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE;

EID: 84880380404     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit256     Document Type: Letter

References (8)

1. Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56:1363-9.
2. Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis 2012; 55:332-42.
3. Hoskins TW, Davies JR, Smith AJ, Miller CL, Allchin A. Assessment of inactivated influenza A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet 1979; 1:33-5.
4. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A 1999; 96:14001-6.
5. World Health Organization. WHO recommendations on the composition of influenza virus vaccines. Available at: http://www.who.int/influenza/vaccines/ virus/recommendations/en/index.html. Accessed 6 May 2013.
6. Skowronski D, Janjua N, De Serres G, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill 2013; 18. pii:20394. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20394. Accessed 6 May 2013.
7. Valenciano M, Kissling E, I-MOVE case-control study team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill 2013; 18: pii:20400. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId= 20400. Accessed 6 May 2013.
8. Centers for Disease Control and Prevention. Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013. MMWR Morb Mortal Wkly Rep 2013; 62:119-23. Available at: http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm6207a2.htm?s-cid=mm6207a2-w. Accessed 6 May 2013.